Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Savonitto

Showing results (31-40 of 210) with videos related to

Pageof 21
Sort By:
The American Journal of Cardiology|June 13, 2025
Cardiogenic shock: need to distinguish between ischemic and non-ischemic cause to define treatment networksStefano Savonitto, Alice Sacco, Nuccia Morici
Aging|September 12, 2018
Antiplatelet therapy for elderly patients with Acute Coronary SyndromesStefano Savonitto, Nuccia Morici, Stefano De Servi
Przeglad Menopauzalny = Menopause Review|August 29, 2018
Perimenopause vasomotor symptoms, coronary atherosclerosis and risk of myocardial infarction during menopause: the cardiologist's perspectiveStefano Savonitto, Luca A Ferri, Delia Colombo
Cardiovascular Drugs and Therapy|August 19, 2020
Antiplatelet Therapy in Elderly Patients with Acute Coronary Syndromes: the Clopidogrel Revenge: Possible Reasons for a Bright ComebackStefano De Servi, Antonio Landi, Stefano Savonitto
Menopause (New York, N.Y.)|June 20, 2018
In ReplyLuca A Ferri, Stefano Savonitto, Nuccia Morici
European Journal of Internal Medicine|May 5, 2026
Should Ticagrelor in association with aspirin be still considered the standard dual antiplatelet treament for acute coronary syndromes ?Stefano De Servi, Claudio Montalto, Stefano Savonitto
European Journal of Internal Medicine|April 6, 2024
Clopidogrel induced reduction in neutrophil count: An overlooked beneficial effect?Stefano De Servi, Antonio Landi, Stefano Savonitto
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
Rivaroxaban in patients with ischaemic chronic cardiomyopathy and obstructive peripheral arterial disease: rationale for treatment and resultsStefano Savonitto, Silvia Pelizzoli, Antonia Maria Selva
European Journal of Internal Medicine|July 30, 2023
Gastrointestinal bleeding, a preventable cause of hospital admission: Time for specific studies in patients on antithrombotic therapyStefano Savonitto, Claudio Montalto, Stefano De Servi
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 6, 2019
Use of direct oral anticoagulant in ischaemic heart disease: the COMPASS studyLuca A Ferri, Giorgio Bassanelli, Stefano Savonitto
Pageof 21

Showing results (31-40 of 210) with videos related to

Sort By:
Pageof 21
The American Journal of Cardiology|June 13, 2025
Cardiogenic shock: need to distinguish between ischemic and non-ischemic cause to define treatment networksStefano Savonitto, Alice Sacco, Nuccia Morici
Aging|September 12, 2018
Antiplatelet therapy for elderly patients with Acute Coronary SyndromesStefano Savonitto, Nuccia Morici, Stefano De Servi
Przeglad Menopauzalny = Menopause Review|August 29, 2018
Perimenopause vasomotor symptoms, coronary atherosclerosis and risk of myocardial infarction during menopause: the cardiologist's perspectiveStefano Savonitto, Luca A Ferri, Delia Colombo
Cardiovascular Drugs and Therapy|August 19, 2020
Antiplatelet Therapy in Elderly Patients with Acute Coronary Syndromes: the Clopidogrel Revenge: Possible Reasons for a Bright ComebackStefano De Servi, Antonio Landi, Stefano Savonitto
Menopause (New York, N.Y.)|June 20, 2018
In ReplyLuca A Ferri, Stefano Savonitto, Nuccia Morici
European Journal of Internal Medicine|May 5, 2026
Should Ticagrelor in association with aspirin be still considered the standard dual antiplatelet treament for acute coronary syndromes ?Stefano De Servi, Claudio Montalto, Stefano Savonitto
European Journal of Internal Medicine|April 6, 2024
Clopidogrel induced reduction in neutrophil count: An overlooked beneficial effect?Stefano De Servi, Antonio Landi, Stefano Savonitto
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
Rivaroxaban in patients with ischaemic chronic cardiomyopathy and obstructive peripheral arterial disease: rationale for treatment and resultsStefano Savonitto, Silvia Pelizzoli, Antonia Maria Selva
European Journal of Internal Medicine|July 30, 2023
Gastrointestinal bleeding, a preventable cause of hospital admission: Time for specific studies in patients on antithrombotic therapyStefano Savonitto, Claudio Montalto, Stefano De Servi
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 6, 2019
Use of direct oral anticoagulant in ischaemic heart disease: the COMPASS studyLuca A Ferri, Giorgio Bassanelli, Stefano Savonitto
Pageof 21